BioSpace News Archive

Daxor Corporation announces a new research letter in the Journal of the American College of Cardiology – Heart Failure validating the benefits of the Company’s BVA-100 diagnostic in optimizing individualized therapy for heart failure patients.

Ultragenyx Pharmaceutical Inc. today announced that it has appointed Howard Horn as executive vice president and chief financial officer (CFO) effective October 16, 2023.

Lumos Pharma, Inc. will participate in the Oppenheimer 2023 Life Sciences Summit to be held July 18th – 20th in Montauk, NY, during which discussions with investors will take place.

Specializing in the growing sector of Advanced Therapy Medicinal Products, the cooperation focuses its efforts on drug delivery solutions and freezing applications for cell and gene therapies.

Abcam plc, a global leader in the supply of life science research tools, held an Extraordinary General Meeting of its shareholders that was convened following a requisition notice from Dr. Jonathan Milner dated May 30, 2023.

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the Company will host a virtual webcast with Prof. Dr. Günter Höglinger, Director of the Department of Neurology at LMU Hospital, Ludwig-Maximilians-University (LMU) Munich, Germany, to discuss the treatment landscape for people living with progressive supranuclear palsy (PSP) and the Company’s clinical development plans for AMX0035 in PSP on July 26, 2023 at 1:30pm ET.

Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company”) is pleased to announce the appointment of Patrick Doody as Nymox Vice President, General Counsel, and Member of Nymox Board of Directors.

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for second quarter 2023 and reiterated full-year guidance.

Tempus, a leader in artificial intelligence and precision medicine, announces its GEMINI Non-small Cell Lung Cancer (NSCLC) study (NCT05236114).

Veeva Systems (NYSE: VEEV) today announced that Merck KGaA, Darmstadt, Germany is using Veeva Vault MedInquiry as its global medical information management system.